The Paris Bioconvergence Biofoundry is a cutting-edge facility dedicated to accelerating research in synthetic biology. It provides advanced automation, high-throughput screening, and genome editing technologies to support the design, construction, and testing of biological systems. The biofoundry fosters innovation, enabling faster development of biotherapies and sustainable biomanufacturing solutions.
IVETh
IVETh is the first expertise and technological innovation HUB dedicated to the bioproduction, engineering, and characterization of extracellular vesicles (EVs) and nanovectors for early diagnosis and personalized therapy development. Our goal is to accelerate technological maturation and transfer, from academic research lab towards patients.
ART-TG
The Technological Research Accelerator in Genomic Therapy (ART-TG) is a biomedical research center established by Inserm, the french national biomedical institution, to promote excellence in gene therapy research.
DICE BioConvS
We are an innovative platform designed to strengthen collaborations within the BioConvs Research community.
Visit our stand to explore our open-source prototype and share your feedback—help us shape it to meet your needs!
Extracellular Vesicle Platform at Institut Curie
The Extracellular Vesicle Platform at Institut Curie, led by internationally recognized experts Coralie Guérin, Lorena Martin-Jaular and Clotilde Théry, offers expertise in isolating, characterizing, and analyzing extracellular vesicles. Following ISEV guidelines, it provides access to advanced instruments, as well as training and advice on biochemical and methodological approaches for EV research.
Core facilities of the Paris Brain Institute
Paris Brain Institute offers cutting-edge core facilities open to external users, providing technologies, training, and expertise in neuroimaging, electrophysiology, microscopy, sequencing, histology, proteomics, cell engineering, vectorology, phenotyping, bioinformatics, biobanking, prototyping, and cognitive-behavioral testing. This integrated environment drives diverse neuroscience research, fostering innovation and discoveries across fundamental, translational, and clinical domains.
Proteom’IC
Proteom'IC is the mass spectrometry applied to proteomics core facility of Institut Cochin, open to all public or private research teams in France and abroad. The platform offers services for quantitative comparisons of proteomes, phosphoproteomes, other post-translational modifications, protein partners, identification or characterization of a protein and multi-omics bio-analyses.
CellAction (Cell therapy Acceleration and Innovation)
CellAction is a unique integrated platform at Institut Curie dedicated to accelerating the development and clinical transfer of innovative cell and gene therapies, particularly CAR-T therapies, for cancer treatment. It brings together top medical-scientific expertise and cutting-edge technology to foster collaborative projects and advance new therapies for patients.
CIMI Simoa Facility
The Simoa (Single Molecule Array) Facility of the Center for Immunology and Microbial Infectious in Paris (CIMI-Paris), located at the Sorbonne University Faculty of Health, Pitié-Salpêtrière site, performs fully automated analyses using the HD-X analyzer (Quanterix) for highly sensitive detection of protein biomarkers, especially in fields like immunology and neurology.
This technical facility is open to public research teams, whether or not they are affiliated with Sorbonne University, through scientific collaboration. The team provides comprehensive project support, from experimental design to final data validation.
Hemostasis and platelet function facility
This platform enables the analysis of platelet function and coagulation. Thrombus formation is visualized in real time via fluorescence microscopy. Hemocytometers, thromboelastometry, thrombinography, and flow cytometry assess haemostatic parameters, thrombin generation, and platelet activation. Blood-derived products support evaluation of platelet aggregation and fibrinolysis.
The Biochemistry and Biophysics (B&B) facility of the Institute of Psychiatry and Neuroscience of Paris (IPNP)
B&B provides molecular biology (cloning, mutagenesis, mRNA production), biochemistry (protein purification/functionalization), and biophysics (protein/nucleic acid analysis, interaction studies) services. Open to public research teams and private companies, B&B also supports project design, monitoring, and offers training accessible beyond IPNP.
High Throughput quantitative PCR Core Facility of the ENS
The qPCR-HD-GPC platform offers public and private research teams, as well as industry, expertise and methods for high-throughput quantitative genome and transcriptome analysis. The microfluidic technologies implemented on the platform enable all quantitative and digital PCR methods to be used for genomic analyses such as Gene Expression variation (GE), Copy number variation (CNV), Search for polymorphisms (SNP) Genotyping, Preparation and quantification of libraries for high-throughput sequencing, Single cell genomics/trancriptomics and Absolute quantification (dPCR and cdPCR).
DIM C-BRAINS
C-BRAINS (Computational and Biomedical Research in AI for Neuroscience) promotes innovation in brain research by supporting projects at the crossroads of neuroscience, biomedical technologies, and artificial intelligence. It funds cutting-edge work on brain function, mental health, and neurodegenerative diseases through interdisciplinary collaboration among labs in Île-de-France.
DIM ITAC
ITAC (Innovations and Translational Approaches in Cancer) fosters translational cancer research by supporting collaborations between clinicians, biologists, and technology developers. The DIM funds projects that accelerate the transfer of scientific discoveries into clinical applications, focusing on diagnostics, therapeutics, and personalized medicine to improve cancer patient outcomes across Île-de-France.
DIM OneHealth2.0
OneHealth2.0 supports interdisciplinary research on global health challenges at the interface of humans, animals, and the environment. It promotes integrated approaches to infectious diseases, antimicrobial resistance, and ecosystem health by bringing together life sciences, environmental sciences, and social sciences to address complex public health issues in the Île-de-France region.
DIM AI4IDF
AI4IDF boosts the integration of artificial intelligence in academic research and public-sector applications across Île-de-France. It supports interdisciplinary projects applying AI to health, environment, society, and technology, and facilitates access to computing infrastructure, expertise, and training to accelerate responsible innovation in data-driven science.